Both in Biotechnology
Senti Biosciences Holdings vs PharmaCyte Biotech
Over the past year SNTI returned −92.3% and PMCB returned −64.5%; their daily moves had a correlation of 0.16.
SNTI −92.3% PMCB −64.5%Growth of $1, one year, split-adjusted
| Metric | SNTI | PMCB |
|---|---|---|
| Price | $0.1732 | $0.3501 |
| Market cap | $5.4M | $3.8M |
| Today | −8.04% | −1.44% |
| 1 month | −47.4% | −20.6% |
| 6 months | −83.7% | −54.1% |
| Year to date | −83.3% | −51.6% |
| 1 year | −91.3% | −63.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −75000.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 98.1× | — |
| Net cash | $2.5M | $30.5M |
| Dividend yield | — | — |
| Volatility (60d) | 94.4% | 62.3% |
| Short % of float | 4.7% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).